Doryen Bubeck,2,
David J. Rowlands,1 and
James M. Hogle2*
School of Biochemistry and Microbiology, University of Leeds, Leeds LS2 9JT, United Kingdom,1 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 021152
Received 13 July 2005/ Accepted 30 September 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
In contrast, nonenveloped viruses require either the entire virion or the highly charged viral genome to pass across the hydrophobic barrier of the host cell membrane. Although details of the cell entry pathway for nonenveloped viruses are not well defined, a general model has been described for poliovirus and related viruses, in which receptor-mediated conformational changes and exposure of hydrophobic viral residues play crucial roles (17).
Poliovirus provides an excellent model system to study nonenveloped virus entry. The genetics and biochemistry of the virus have been studied extensively, and preliminary structural information has been obtained for several stages of the virus life cycle (1, 2, 4). Poliovirus is a member of the enterovirus genus of the picornavirus family and is closely related to a number of other important pathogens including rhinoviruses, coxsackieviruses, and echoviruses. These viruses contain a positive-sense RNA genome (7,000 to 8,000 nucleotides in length) enclosed in an icosahedral protein shell consisting of four capsid proteins (VP1 to VP4) (27).
Infection is initiated when the virus attaches to a specific receptor, the poliovirus receptor (PVR or CD155), a cell adhesion molecule-like protein belonging to the nectin family (29). The receptor has an ectodomain composed of three immunoglobulin-like domains, a transmembrane region, and C-terminal cytoplasmic tail (24). The ectodomain can be transferred to a variety of anchors (28), including a glycosyl-phosphatidylinositol anchor (30), and remain fully functional for virus entry, demonstrating that neither the transmembrane nor the cytoplasmic domains play an essential role. The structure of the poliovirus-PVR complex has been solved by cryoelectron microscopy (cryo-EM) (2, 15, 16, 35) and shows that receptor molecules bind in a deep depression or "canyon" that surrounds the fivefold axis of the icosahedral virus particle.
At physiological temperatures, receptor binding initiates the cell entry process (8, 9, 22) by lowering the activation energy of a reaction, which causes an irreversible conformational change in the virus capsid (32). This conversion produces a particle with altered sedimentation properties (from 160S of the virion to 135S), antigenicity, and sensitivity to proteases. This particle is generally known as the 135S or A particle. The conformational changes include the externalization of both the amino terminus of VP1 (12) and the small internal myristoylated protein, VP4 (6, 9, 14). At room temperature, both VP4 and the amino-terminal extension of VP1 are completely enclosed in the native virion protein shell (18) but are transiently and reversibly exposed at physiological temperatures (21). The exposed N terminus of VP1 allows the 135S particle to attach to lipid membranes in a receptor-independent manner (12); the externalized VP4 also partitions into membranes during infection (7). Both 135S particles and virus-receptor complexes have been shown to form channels in membranes (7, 31). Furthermore, the ability of viruses with mutations in VP4 to form channels correlates with their ability to infect cells (7).
After the conversion to 135S, the virus undergoes a second conformational change in which the viral RNA is ejected, resulting in the production of an empty particle which sediments at 80S. The 80S particle is antigenically distinct from both the 135S particle and native virus (12, 19). The trigger for RNA release is unknown.
Structures of the 135S and 80S particles have been solved by using cryo-EM (1, 4). To aid in their interpretation, pseudoatomic models for these structures have been derived by docking atomic level-resolution models of the capsid proteins into cryo-EM reconstructions. Together, biochemical and structural information has led to a working model for the early steps of poliovirus infection in which the receptor captures the virus, orients it appropriately at the cell surface, and catalyzes conformational changes. These changes result in the insertion of viral protein sequences in a cell membrane to form a pore or hole in the membrane through which the viral RNA is translocated into the cytoplasm (1, 4, 17). Although this model is consistent with available data (including the link between the ability to make channels and the ability to release RNA), it is also possible that the inserted sequences disrupt membranes, resulting in the release of the 135S particle or externalized RNA into the cytoplasm.
Despite the wealth of structural and biochemical information, there are several key steps in the cell entry pathway that remain poorly understood. It is known that infection with poliovirus is not obligatorily dependent on acidification of endosomes or on dynamin-requiring processes such as classical clathrin-mediated endocytosis or internalization via caveoli (10). However, the site of RNA translocation (cell surface, intracellular vesicle), the trigger for RNA release, and the precise nature of the RNA translocation complex remain unknown.
Addressing these important questions will require a variety of approaches. One of the key obstacles to further understanding is the lack of an appropriate model system to bridge the considerable gap between studies using whole cells and studies using soluble particles. In this paper, we describe the development of a simple liposome-based model system for biochemical and structural characterization of the early steps in poliovirus entry. In this model, liposomes which incorporate lipids with nickel-charged nitrilotriacetic acid (NTA) head groups are used to capture recombinantly expressed PVR ectodomains containing a C-terminal (membrane-proximal) His tag. These receptor-decorated liposomes are used as simple surrogates for cells. The model circumvents the need to reconstitute full-length receptor into membranes and provides a convenient way to control many of the parameters that may be involved in cell entry. We show that receptor-decorated liposomes are capable of (i) capturing virus, (ii) inducing the virion-to-135S particle transition, and (iii) facilitating the externalization of VP4 and the N terminus of VP1 and the formation of a receptor-independent 135S particle-membrane complex, mediated by the newly exposed N terminus of VP1.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Virus particles containing radiolabeled capsid proteins were produced using medium deficient in L-methionine and with the addition of [35S]methionine to the culture 3.5 h postinfection, to yield purified virus with a specific activity on the order of 4 x 105 cpm/µg.
Preparation of liposomes. Phosphatidylethanolamine, phosphatidylcholine, sphingomyelin, cholesterol, and phosphatidic acid were supplied in chloroform (Avanti Polar Lipids) and mixed in molar ratios of 1:1:1:1.5:0.3, respectively (12). Chloroform was evaporated with a stream of argon, leaving a thin lipid film, which was dried overnight under vacuum. Dried lipid was rehydrated at a concentration of 1 mg/ml in 50 mM HEPES (pH 7.3) and 50 mM NaCl, thoroughly mixed by vortexing, and extruded through a 0.1-µm-pore-size membrane (Avanti Polar Lipids) to form a homogeneous population of unilamellar vesicles with a diameter approximately equivalent to the pore size. Liposomes were freshly prepared for each experiment.
Fluorescence-labeled liposomes were generated by the inclusion of phosphatidylethanolamine with lissamine rhodamine B-labeled head groups (Avanti Polar Lipids), at a final concentration of 0.5% (wt/wt), prior to evaporation of chloroform from the lipid mixture.
Nickel-charged liposomes, for binding of the His-tagged receptor, were similarly generated by the inclusion of the nickel salt of 1,2-dioleoyl-sn-glycero-3-{[N(5-amino-1-carboxypentyl)iminodiacetic acid] succinyl} (designated DOGS-NTA-Ni; Avanti Polar Lipids), at a final concentration of 20% (wt/wt) unless otherwise stated; they are referred to as NTA-liposomes.
Formation of receptor-decorated liposomes. Soluble PVR consisting of the ectodomain (amino acids 1 to 337) without the transmembrane and cytoplasmic domains and with a six-histidine tag at the C terminus (sPVRHis) was expressed in stably transformed mammalian cells and purified as previously described (23); it was a gift from V. R. Racaniello (Columbia University College of Physicians and Surgeons, New York, N.Y.).
Nickel-chelating liposomes with a total lipid concentration of approximately 1 mg/ml were incubated at room temperature (<25°C) in 50 mM HEPES (pH 7.3), 50 mM NaCl, with sPVRHis at a final concentration of 100 µg/ml. After 10 min, a further 100 µg of receptor/ml was added and incubated for an additional 10 min. Receptor-decorated liposomes were purified from unbound material by flotation through Ficoll gradients.
Virus binding to liposomes. Samples of purified receptor-decorated liposomes containing approximately 1-mg/ml lipid and 0.5-mg/ml bovine serum albumin (BSA) in 50 mM HEPES (pH 7.3)-50 mM NaCl were mixed at room temperature with radiolabeled poliovirus in a final volume, typically of 100 µl. Virus was used at nonsaturating amounts (0.2 µg) or in excess (20 µg), depending on the experiment.
Ficoll gradient liposome flotation. The liposome sample was adjusted to contain Ficoll at a final concentration of 20% (wt/vol) and was overlaid with 10% (wt/vol) Ficoll, followed by buffer alone. After centrifugation at 100,000 x g at 20°C for 30 min, gradients were fractionated from the top. Fractions were analyzed for the presence of liposomes by visualization of rhodamine, for the presence of receptor by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie staining, or for the presence of radiolabeled virus by liquid scintillation counting (Packard Tri-Carb 1900TR). Alternatively, for preparative purposes, the visible floated liposome band was harvested from the gradient at the interface between the 10% Ficoll and buffer layers.
Temperature dependence of conversion. Receptor-decorated or nondecorated liposomes (10 µg of lipid) were incubated with 0.5 µg of radiolabeled poliovirus for 5 min at 37°C or room temperature in 50 mM HEPES (pH 7.3)-50 mM NaCl before analysis of particles by sedimentation through sucrose gradients. A broader temperature range was sampled by incubating the virus-receptor-liposome complexes for 32 min at room temperature, 31°C, 33°C, 35°C, 37°C, or 39°C. The longer incubation time was chosen to facilitate detection of potentially inefficient conversion at suboptimal temperatures.
Time course of conversion. Receptor-decorated liposomes (10 µg of lipid) were incubated with 0.2 µg of radiolabeled poliovirus (nonsaturating amounts) at room temperature in 50 mM HEPES (pH 7.3) and 50 mM NaCl. The use of nonsaturating levels of input virus ensured that the majority of virus was bound to liposomes at the start of the time course (data not shown). Samples were then diluted 1:20 into the same buffer (prewarmed) and incubated at 37°C for 0.5, 2, 8, and 32 min. The reactions were stopped at each time point by rapid freezing in liquid nitrogen.
Effect of receptor density on conversion. Receptor-decorated liposomes were prepared as described above, except that they contained DOGS-NTA-Ni in the range of 2 to 20% (wt/wt). Liposomes (100 µg of lipid) were mixed with 20 µg of radiolabeled poliovirus (saturating amounts). Virus-receptor-liposome complexes were separated by flotation through Ficoll gradients and incubated at 37°C for 40 min.
Release of virus from liposome complexes. Receptor-decorated liposomes (100 µg of lipid) were mixed with 20 µg of radiolabeled poliovirus (saturating amounts) at room temperature. Liposome-receptor-virus complexes were purified in a preparatory Ficoll flotation step. The complexes were then incubated at room temperature or 37°C for 40 min, cooled to room temperature, and adjusted to 1.5 M imidazole to disrupt receptor-virus interactions, or they were mock treated. Intact liposome-particle complexes were then purified by an additional flotation through Ficoll. Purified liposome fractions containing liposome-particle complexes were then subjected to digestion by Staphylococcus aureus V8 protease (Sigma) by incubation for 30 min at room temperature with protease at 200 µg/ml.
Sucrose gradient sedimentation of particles. Particles were extracted from liposome samples by 10-fold dilution and then solubilization of the lipid membranes with the addition of Triton X-100 to a concentration of 0.5%. Debris was pelleted in a microcentrifuge at 12,000 x g for 5 min, and the supernatant was layered onto 15 to 30% sucrose gradients and subjected to centrifugation for 35 min at 50,000 rpm and 4°C in a Sorvall AH650 rotor.
Analysis of particles released from liposomes was carried out by first separating particles from liposomes in Ficoll gradient flotations. The bottom two fractions of such flotation gradients, containing released particles, were then diluted 10 fold, layered onto 15 to 45% sucrose gradients, and subjected to centrifugation for 3.5 h at 25,000 rpm and 4°C in a Sorvall AH629 rotor.
All gradients were fractionated from the bottom, and the presence of radiolabeled virus particles was detected by liquid scintillation counting. Gradient profiles are displayed with values as percentages of the total counts per minute across the gradient, to simplify the comparison of samples with various signal strengths.
The nature and complexity of these experiments do not facilitate the direct comparison of data from separate experiments; however, all data shown are representative of the trends observed in experiments that have been repeated at least two or three times.
| RESULTS |
|---|
|
|
|---|
|
|
|
The temperature dependence of virus conversion was further investigated by incubating liposomes for 32 min with nonsaturating amounts of radiolabeled virus at room temperature, 31°C, 33°C, 35°C, 37°C, or 39°C (Fig. 4). Efficient conversion to particles with altered sedimentation was seen only at 37°C and 39°C.
|
|
The density of receptors on the liposome surface dictates the efficiency of virus conversion. By changing the proportion of nickel-chelating lipids present in liposomes, the capacity for binding sPVRHis could be altered, enabling the formation of liposomes with a range of receptor densities. There was a linear relationship between the proportion of NTA-lipid (0 to 20%) in liposomes and their capacity for binding receptor (data not shown). Receptor-decorated liposomes, containing between 2 and 20% nickel-chelating lipid, were mixed at room temperature with excess virus. Liposome-receptor-virus complexes were separated from unbound virus in a preparatory flotation step. The purified liposome-receptor-virus complexes were then incubated at 37°C for 40 min, after which particles were extracted with detergent and analyzed by ultracentrifugation through sucrose density gradients. Radioactive counts in gradient fractions corresponding to native or converted particles were summated to display the relative proportion of these particles with increased clarity. Receptor-decorated liposomes containing between 10 and 20% NTA-lipid induced efficient conversion of virus at 37°C (Fig. 6). However, reducing the proportion of NTA-lipid in liposomes to <10% caused a dramatic reduction in the levels of particle conversion (Fig. 6), indicating that under these conditions sufficient receptor molecules were present on liposomes to allow virus binding but not efficient conversion.
|
The interaction between sPVRHis and NTA-liposomes could be disrupted with imidazole, allowing liposomes to be separated from receptor by flotation in Ficoll gradients. The removal of receptor from liposomes by this method was confirmed by SDS-PAGE of flotation gradient fractions (data not shown). By this procedure, both receptor and receptor-bound virus could be removed from liposomes, facilitating analysis of the remaining proportion of virus particles that were interacting directly with the membrane. By carrying out this procedure before and after virus conversion, we were able to investigate the effect of particle conversion on virus-membrane interactions.
Purified virus-receptor-liposome complexes were incubated at 37°C for 40 min to induce conversion or maintained at room temperature. Liposome-receptor interactions were disrupted by adjusting samples to 1.5 M imidazole, and membrane-associated particles were then separated from unbound material by flotation assay. The concentration of imidazole used in these experiments was higher than is normally required to disrupt nickel-histidine affinity, due to the need to disrupt multiple tethers to release virions; however, previous studies have shown that binding of 135S particles to liposomes is not disrupted by high salt concentrations (12).
In samples maintained at room temperature, the attachment of virus to liposomes was almost entirely dependent on receptor binding; release of virus from liposomes was concomitant with removal of receptor by imidazole treatment (Fig. 7A, panels 1 and 2). After incubation at 37°C, a proportion of virus spontaneously released from liposomes (Fig. 7A, panel 3), presumably as a result of converted particles being released from the receptor without becoming membrane anchored. In samples treated sequentially with elevated temperature followed by imidazole, further release of virus was observed; however, a significant proportion of particles reproducibly remained liposome associated (Fig. 7A, panel 4), presumably due to a membrane interaction mediated by the externalized N terminus of VP1.
|
To confirm the identity of particles released from liposomes by V8 protease, their sedimentation was measured by sucrose density gradient analysis (Fig. 8). Liposomes were mixed with excess amounts of radiolabeled virus so that multiple rounds of receptor-driven conversion could occur. After incubation with receptor-decorated liposomes at 37°C (or room temperature), samples were cooled to room temperature and incubated either with or without V8 protease. Unbound particles were separated from liposomes in flotation gradients before centrifugation through sucrose gradients. In samples incubated at 37°C and mock digested, only 80S particles were found not associated with liposomes, presumably being particles eluted from the liposome-receptor complex during conversion. However, after both temperature-induced conversion and V8 digestion, both 80S and 135S particles were now observed. This indicated that 135S particles formed during virus conversion become attached to the liposome by a VP1-membrane interaction and are released by V8 digestion. In control reactions at ambient temperature or with undecorated liposomes, only residual excess 160S particles were detected.
|
|
| DISCUSSION |
|---|
|
|
|---|
In this system, the level of radiolabeled virus binding to liposomes at ambient temperature was measured by flotation assays in which the majority of nonsaturating levels of virus were shown to comigrate with floated receptor-decorated liposomes. Virus binding was shown to be mediated specifically by the presence of the PVR ectodomain on the surface of liposomes. At temperatures close to physiological conditions, receptor-decorated liposomes induced the conversion of virus to 135S and 80S entry-intermediate particles. Particles were identified by sedimentation through sucrose density gradients after the liposomes were solubilized with detergent.
The minimum temperature required for efficient conversion was close to physiological conditions (between 35°C and 37°C), similar to those reported previously for conversion of virus with soluble receptor (13). Receptor-decorated liposomes induced a rapid rate of virus conversion at 37°C, with efficient conversion to 135S particles observed after 30 s, followed by further conversion of a proportion of these particles to 80S after 2 min. This population of particles appeared relatively stable, longer incubations or elevated temperature (39°C) caused no further conversion to 80S. Both the rate of conversion to 135S and the percentage of 135S particles that remains associated with the membrane are greater with the receptor-decorated liposomes than with receptor-expressing cells. The rate of conversion using the liposome model system also supersedes that for conversion with excess soluble receptor (13). This may indicate that the levels of receptor are superoptimal in the liposome system. Alternatively, it may be attributed to the increased accessibility of the membrane surface on the liposomes, which lack an extracellular matrix.
Although the trigger for conversion to the 80S particle remains unclear, the 135S particles appeared to be stabilized in this system by the presence of serum or purified BSA. In the absence of these components, virus conversion was able to proceed directly to the 80S particle, independent of both temperature and receptor (data not shown), perhaps triggered by a membrane interaction resulting from transient externalization of VP1. Previous studies have documented the ability of BSA (or fatty acid components present in preparations of BSA) or myristate to stabilize picornavirus particles (11, 33, 34). In the current study, BSA may also have stabilized the virus, leading to reduced virus breathing and therefore reduced nonreceptor-mediated membrane interaction.
The working model for poliovirus infection predicts that the fivefold axis of virus particles is the site of membrane interaction, allowing for multiple copies of membrane-anchored PVR to attach to receptor binding sites around the fivefold axis. We investigated the potential requirement for multiple receptor interactions by reducing the proportion of nickel-chelating lipids in the total lipid composition, thus limiting the number of receptor molecules per liposome. At high receptor densities, conversion of virus was efficient, suggesting that the required number of receptor binding sites on the virus had been saturated. When the receptor density was lowered, virus remained able to bind to liposomes, but conversion now appeared to be much less efficient, suggesting that multiple receptor interactions may indeed be required in vivo.
Receptor molecules could be removed from liposomes by disrupting the nickel-histidine interaction with imidazole and floating liposomes away from released receptor molecules. At ambient temperatures, liposome-bound virus was also released during this process, indicating that virus-liposome interactions were receptor mediated. After conversion at physiological temperature, a proportion of particles remained membrane associated, independent of the receptor. A proportion of these converted particles were released by the action of V8 protease, which specifically cleaves the externalized N terminus of VP1 (12), thus confirming the VP1-mediated membrane interaction of converted particles. Incomplete release of particles by V8 may indicate that VP1 was partially protected from proteolytic cleavage by virtue of being inserted in the membrane. Although approximately 50% of converted particles could be released from liposomes by protease, the level of VP1 cleavage of remaining liposome-associated particles was much higher than this when analyzed by SDS-PAGE (data not shown), suggesting that VP1 was externalized and available for cleavage at each fivefold axis of the virus, except for those partially membrane-protected molecules of VP1 at the membrane-proximal axis.
After receptor-driven conversion, VP4 was shown to be absent from released particles and to accumulate in the liposome membrane, in agreement with previous studies showing loss of VP4 from the virus (6, 9) and the insertion of VP4 into the membrane during infection of the cell (7).
The externalization of VP4 and the N terminus of VP1 is triggered by receptor binding. It is clear that these components interact with the membrane and that VP4 is also involved in both the formation of channels with electrical conductance (30, 31) and delivery of RNA into the cytoplasm (7). The formation of size-selective membrane pores by a minor group rhinovirus has been elegantly demonstrated in experiments using endosomes isolated from virus-infected cells (3, 26). A recent study also provided the first visualization of the exit of RNA from a minor group human rhinovirus, in which release of RNA is triggered by exposure to low pH (20). Although this work clearly indicates that RNA exits the particle from a single point, presumably a fivefold axis, little is known about the mechanism which allows RNA to exit in such a coordinated manner. For viruses such as poliovirus, which can infect cells independently of endosomal acidification (25), the trigger for genome release remains unknown.
The NTA-liposome system developed in this study provides a controlled environment in which the biochemical characteristics of entry can be explored, with the flexibility to study the effects of further factors such as lipid composition, membrane curvature, membrane potential, and the inclusion of cellular components. The topology of the receptor-decorated liposome membrane is similar to that encountered by virus particles at the cell surface. With simple modifications, the system could be adapted to trap the virus-receptor complex on the inside surface of the liposome, mimicking the situation where the virus has been taken up in an endocytic vesicle. This strategy would also greatly facilitate exploration of conditions that could result in the release of the viral RNA and its translocation across the membrane.
In addition to biochemical assays, this model membrane system can be used for structural studies to explore the mechanism of nonenveloped virus cell entry. Recently, it has been used to produce the first visualization of the native poliovirus-receptor-membrane complex by cryo-EM (5). In this structure, the binding of five receptors orients the viral fivefold axis towards the membrane and causes a deformation of the lipid bilayer. Further analysis using cryo-EM of entry intermediates imbedded within the membrane could lead to visualization of a pore, with the ultimate goal of catching the virus in the process of RNA translocation.
| ACKNOWLEDGMENTS |
|---|
This work was supported by NIH grant AI20566 (to J.M.H.), a National Science Foundation predoctoral fellowship (to D.B.), and the Medical Research Council, United Kingdom.
| FOOTNOTES |
|---|
These authors contributed equally to this work. ![]()
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|